Adrenal gland – Strong and diffuse PGP9.5 immunostaining in all tumor cells of a pheochromocytoma.
Adrenal gland - Strong and diffuse PGP9.5 immunostaining in all tumor cells of a pheochromocytoma. 
Breast – PGP9.5 negative breast cancer of no special type (NST).
Breast - PGP9.5 negative breast cancer of no special type (NST). 
Colon – PGP9.5 negative colorectal adenocarcinoma. A positive staining is seen in nerve fibres.
Colon - PGP9.5 negative colorectal adenocarcinoma. A positive staining is seen in nerve fibres. 
Esophagus – PGP9.5 negative adenocarcinoma.
Esophagus - PGP9.5 negative adenocarcinoma. 
Kidney – Chromophobe renal cell carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Kidney - Chromophobe renal cell carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern). 
Kidney – PGP9.5 negative clear cell carcinoma.
Kidney - PGP9.5 negative clear cell carcinoma. 
Larynx – Squamous cell carcinoma showing strong PGP9.5 positivity in tumor cells.
Larynx - Squamous cell carcinoma showing strong PGP9.5 positivity in tumor cells. 
Liposarcoma with moderate intensity PGP9.5 immunostaining.
Liposarcoma with moderate intensity PGP9.5 immunostaining. 
Liver – Cholangiocellular carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).
Liver - Cholangiocellular carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern). 
Oral cavity – Squamous cell carcinoma showing strong PGP9.5 positivity in most tumor cells.
Oral cavity - Squamous cell carcinoma showing strong PGP9.5 positivity in most tumor cells. 
Ovary – Endometroid carcinoma with strong PGP9.5 staining in most tumor cells.
Ovary - Endometroid carcinoma with strong PGP9.5 staining in most tumor cells. 
Ovary – Serous high-grade carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Ovary - Serous high-grade carcinoma showing variable intensity PGP9.5 staining in tumor cells (mosaic pattern). 
Ovary – Serous high-grade carcinoma with moderate to strong PGP9.5 staining in tumor cells.
Ovary - Serous high-grade carcinoma with moderate to strong PGP9.5 staining in tumor cells. 
Pancreas – Neuroendocrine tumor with strong diffuse PGP9.5 immunostaining.
Pancreas - Neuroendocrine tumor with strong diffuse PGP9.5 immunostaining. 
Pancreas – Neuroendocrine tumor with weak PGP9.5 immunostaining in only a few tumor cells.
Pancreas - Neuroendocrine tumor with weak PGP9.5 immunostaining in only a few tumor cells. 
Pleura – Malignant (epitheloid) mesothelioma with PGP9.5 immunostaining of variable intensity (mosaic pattern).
Pleura - Malignant (epitheloid) mesothelioma with PGP9.5 immunostaining of variable intensity (mosaic pattern). 
Pleura – Strong PGP9.5 immunostaining in a malignant (epitheloid) mesothelioma.
Pleura - Strong PGP9.5 immunostaining in a malignant (epitheloid) mesothelioma. 
Prostate – PGP9.5 negative adenocarcinoma (Gleason 3+3=6).
Prostate - PGP9.5 negative adenocarcinoma (Gleason 3+3=6). 
Skin – Merkel cell carcinoma showing strong PGP9.5 immunostaining.
Skin - Merkel cell carcinoma showing strong PGP9.5 immunostaining. 
Stomach – PGP9.5 negative adenocarcinoma (intestinal type).
Stomach - PGP9.5 negative adenocarcinoma (intestinal type). 
Testis – Embryonal carcinoma showing a moderate to strong PGP9.5 immunostaining in cancer cells.
Testis - Embryonal carcinoma showing a moderate to strong PGP9.5 immunostaining in cancer cells. 
Testis – Seminoma showing a strong PGP9.5 immunostaining in tumor cells.
Testis - Seminoma showing a strong PGP9.5 immunostaining in tumor cells. 
Testis – Seminoma with variable intensity PGP9.5 staining in tumor cells (mosaic pattern).
Testis - Seminoma with variable intensity PGP9.5 staining in tumor cells (mosaic pattern). 
Testis – Seminoma with weak to moderate PGP9.5 staining in tumor cells.
Testis - Seminoma with weak to moderate PGP9.5 staining in tumor cells. 
Thyroid – Anaplastic carcinoma with moderate to strong PGP9.5 positivity in tumor cells.
Thyroid - Anaplastic carcinoma with moderate to strong PGP9.5 positivity in tumor cells. 
Thyroid – Medullary carcinoma showing strong PGP9.5 immunostaining.
Thyroid - Medullary carcinoma showing strong PGP9.5 immunostaining. 
Urinary bladder – Muscle-invasive urothelial carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).
Urinary bladder - Muscle-invasive urothelial carcinoma showing PGP9.5 immunostaining of variable intensity in cancer cells (mosaic pattern).